Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.45.1.13-22.2001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Dose Selection in Preclinical Studies: Cross-Species Dose Conversion

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
2020English

A Preliminary Investigation Into the Use of Edge Illumination X-Ray Phase Contrast Micro-Ct for Preclinical Imaging

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Use of a Clinical PET/MR Scanner for Preclinical Research With First Results

EJNMMI Physics
InstrumentationNuclear MedicineRadiologyRadiationImagingBiomedical Engineering
2014English

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2018English

Time-Lapse Algorithms and Morphological Selection of Day-5 Embryos for Transfer: A Preclinical Validation Study

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

A Preclinical Approach for Gene Therapy of Β-Thalassemia

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2010English

ODM-201, a New Generation Androgen Receptor Inhibitor for Castration-Resistant Prostate Cancer: Preclinical and Phase I Data.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Validation of the Filovirus Plaque Assay for Use in Preclinical Studies

Viruses
VirologyInfectious Diseases
2016English

Computational Identification and Validation of Alternative Splicing in ZSF1 Rat RNA-seq Data, a Preclinical Model for Type 2 Diabetic Nephropathy

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy